For Everyone
-
General Public Communication and Education Resources
- TB Questions and Answers Booklet
- What You Need to Know About TB Fact Sheet
- What You Need to Know About the TB Skin Test Fact Sheet
- Introduction to TB Slide Set
- 4R Regimen Medication Tracker
- 3HP Regimen Medication Tracker
- 3HR Regimen Medication Tracker
- TB – Get the Facts! Brochure
- Staying on Track with TB Medicine Booklet
- Think TB Poster
- Stop TB Poster
Health Care Providers
-
Health Care Provider Communication and Education Resources
- TB 101 for Health Care Workers
- TB 101 for Health Care Workers: Continuing Education Activities
- Self-Study Modules on TB
- Self-Study Modules on TB 1-5: Continuing Education Activities
- Self-Study Modules on TB 6-9: Continuing Education Activities
- Core Curriculum on TB: What the Clinician Should Know
- Core Curriculum on TB: Continuing Education Activities
- Latent TB Infection: A Guide for Primary Health Care Providers
- LTBI: Summary of U.S. Recommendations
Public Health
-
Dear Colleague Letters
- CDC Releases 2023 Provisional U.S. TB Data
- Tuberculosis Trials Consortium Launches New TB Clinical Trial
- CDC Releases “Reported Tuberculosis in the United States, 2022”
- CDC Releases New TB Resources for Uniting for Ukraine Arrivals
- Rapid Testing for Fluoroquinolone Resistance
- TB Drug Supply Interruptions and Shortages
- Updates to Provisional BPaL Guidance
- A Letter from Dr. Rochelle P. Walensky, CDC Director, on World TB Day
- U.S. World TB Day 2023 Resources
- Submission of 2023 TB Cases via 2020 RVCT
- CDC Releases “Reported Tuberculosis in the United States, 2021”
- TB Centers of Excellence for Training, Education, and Medical Consultation Selection
- Venezuelan Humanitarian Relief Program and TB Testing
- Timing of TST or IGRA with JYNNEOS Vaccine
- Uniting for Ukraine – Drug Resistance Background and Recommendations
- Uniting for Ukraine Program
- A Letter from Dr. Rochelle P. Walensky, CDC Director, on World TB Day
- Think. Test. Treat TB: Campaign Announcement
- Interim Guidance on a Four-Month TB Treatment Regimen
- CDC Releases Provisional BPaL Guidance to Treat Drug-Resistant TB Disease
- In-Person vs Electronic Directly Observed Therapy for TB Treatment Adherence
- U.S. World TB Day 2022 Resources
- Surveillance Definitions for Extensively Drug Resistant (XDR) and Pre-XDR TB